STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||
| Income Statement [Abstract] | ||||||
| NET SALES | $ 25,605 | $ 19,355 | $ 48,522 | $ 49,772 | ||
| COST AND EXPENSE | ||||||
| Cost of sales | 3,463 | 5,491 | 5,175 | |||
| Research and development | 2,641,941 | 4,362,258 | 5,731,159 | 8,982,920 | ||
| General and administrative | 2,985,883 | 1,896,672 | 4,822,935 | 3,152,122 | ||
| TOTAL COST AND EXPENSE | 5,631,287 | 6,258,930 | 10,559,585 | 12,140,217 | ||
| LOSS FROM OPERATIONS | (5,605,682) | (6,239,575) | (10,511,063) | (12,090,445) | ||
| OTHER INCOME (EXPENSE) | ||||||
| Interest income | 168,253 | 251,730 | 356,101 | 505,066 | ||
| Commitment fee | (235,801) | (28,982) | (243,830) | (105,959) | ||
| Gain (loss) on disposal of property and equipment | 28,800 | (3,166) | ||||
| Other income (expense) | 1,098 | (2,857) | 836 | (5,091) | ||
| NET LOSS | $ (5,672,132) | $ (6,019,684) | $ (10,369,156) | $ (11,699,595) | ||
| LOSS PER SHARE | ||||||
| Basic | $ (0.05) | $ (0.05) | $ (0.08) | $ (0.10) | ||
| Diluted | $ (0.05) | $ (0.05) | $ (0.08) | $ (0.10) | ||
| WEIGHTED AVERAGE NUMBER OF SHARES | ||||||
| Basic | [1] | 125,271,407 | 120,179,570 | 124,605,324 | 119,552,430 | |
| Diluted | [1] | 125,271,407 | 120,179,570 | 124,605,324 | 119,552,430 | |
| ||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|